IOZK article by Prof. Schirrmacher in "Deutsche Zeitschrift für Onkologie" on the basics of immunotherapy
A specialist article by Prof. Schirrmacher appears in "Deutsche Zeitschrift für Onkologie". It explains the basics of immunotherapy and uses examples to show which strategies have achieved particularly promising results.
"Advances in cancer treatment are urgently needed to increase the effectiveness of treatment. Over the past 20 years, immunotherapy has developed significantly as a new biological form of treatment. Thanks to impressive clinical results with newly approved immunotherapeutic drugs, in particular immune checkpoint inhibitors, immunotherapy has become even more important. It is characterized by a higher tumour specificity compared to chemotherapy and radiotherapy."
